Infants born to mothers with chronic hepatitis B are recommended to have serological testing 3–12 months after they complete the primary hepatitis B vaccine course
It is recommended that levels of hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs) in infants born to mothers with chronic hepatitis B are measured 3–12 months after they complete the primary vaccine course. Do not test the infant before 9 months of age, to avoid detecting anti-HBs from the hepatitis B immunoglobulin given at birth. See Infants born to mothers who are hepatitis B surface antigen–positive are recommended to receive both hepatitis B vaccine and HBIG.
- hepatitis B surface antigen
- antibody to hepatitis B surface antigen
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/recommendations/infants-born-to-mothers-with-chronic-hepatitis-b-are-recommended-to-have-serological.